Search
Accendra Health Ord Shs
ACHAdd to Watchlist
3.090USD
-0.250-7.49%
Close 07-31 16:00（ET）Quotes delayed by 15 min
236.64MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Hold
Current Rating
4.390
Target Price
+42.07%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Accendra Health Ord Shs
ACH
5
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Accendra Health Ord Shs's expected revenue for the next quarter?
Accendra Health Ord Shs's expected revenue is 627.31M.
How have Accendra Health Ord ShsACH's recent earnings per share performed?
The market expectation was USD -0.08, while Accendra Health Ord ShsACH's earnings per share (EPS) for the previous quarter was USD -0.74. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Accendra Health Ord Shs?
Based on the ratings of Accendra Health Ord Shs's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.